Device Debut: Zimmer Biomet's Sidus Stemless Shoulder Will Take On Wright's Simpliciti
Executive Summary
US FDA cleared the Sidus total shoulder arthroplasty system for patients with "good bone stock" who have osteoarthritis, posttraumatic arthrosis, focal avascular necrosis of the humeral head, or a previous shoulder surgery that does not compromise the fixation. The company is planning to launch it in the US by the end of the quarter.
You may also be interested in...
Market Intel: Innovation Drives Growth, Draws Younger Patients In Joint Replacement Implants Market
The worldwide joint-replacement implants market is expected to hit $20bn by 2022, according to a new report from Meddevicetracker. The growth is driven by the rising number of elderly patients, whose natural joints have been damaged by arthritis, and the rising prevalence of chronic diseases, such as obesity and diabetes, and sport-related injuries. But a look at the market and the three largest segments – shoulder, knee and hip replacements – show that new technological advancements and improved surgical techniques are increasingly making joint replacement surgeries an option for younger people as well. Here's an overview and key insights from two orthopedic surgeons on the current market and key growth drivers and limiters.
Wright Place, Wright Time? Ortho Specialist's Focus Is Paying Off
In reinventing itself as a niche specialist in the orthopedic market, Wright Medical is putting efforts into maintaining leadership in the upper and lower extremities and building on its biologics strengths – a sales platform that was reinforced highly synergistically on the acquisition of Tornier. But for however long Wright Medical can remain independent, how does it balance value-based health care with strategic development plans?
Minute Insight: Abbott Rolls Out Navitor Next-Gen TAVR System To Catch Up To Medtronic And Edwards
Navitor is an upgraded version of Abbott’s Portico TAVR system with a better fabric cuff and large curved aortic “cells” to reduce the risk of injury to the native valve.